Better Late than Never: Eventual Seroconversion against SARS-CoV-2 in a Kidney Transplant Recipient after Repeated Immune Challenge and Monoclonal Antibody Therapy.
(2021) Kidney International — Vol. 100, n° 5, p. 1131-1132 (2021)
Files
DeGreefetalBetterlatethanneverEventualseroconversionagainstSARS-CoV-2KidneyInt.pdf
Open Access - Adobe PDF
- 577.2 KB
Details
- Authors
- Abstract
- (en) To the editor: Kidney transplant recipients are disproportionately affected by coronavirus disease 2019 (COVID-19). In addition to limited therapeutic options, concerns have arisen regarding poor vaccine efficacy in this population.[...]
- Affiliations
Citations
De Greef, J., Devresse, A., Saad Albichr, I., Scohy, A., Kanaan, N., Georgery, H., Belkhir, L., Kabamba-Mukadi, B., Yombi, J. C., & Goffin, E. (2021). Better Late than Never: Eventual Seroconversion against SARS-CoV-2 in a Kidney Transplant Recipient after Repeated Immune Challenge and Monoclonal Antibody Therapy. Kidney International, 100(5), 1131-1132. https://doi.org/10.1016/j.kint.2021.08.018 (Original work published 2021)